Mineralys Therapeutics, Inc. MLYS Common Stock Shares Issued
Common Stock Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.
The official record: Mineralys Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s common stock shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s common stock shares issued?
- Mineralys Therapeutics, Inc. (MLYS) reported common stock shares issued of 82.5M in Q1 2026.
- How has Mineralys Therapeutics, Inc.'s common stock shares issued changed year-over-year?
- Mineralys Therapeutics, Inc.'s common stock shares issued increased by 27.1% year-over-year, from 64.9M to 82.5M.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s common stock shares issued?
- Over 3 years (2022 to 2025), Mineralys Therapeutics, Inc.'s common stock shares issued has grown at a 133.3% compound annual growth rate (CAGR), from 6.4M to 81.5M.
- What does common stock shares issued mean?
- The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.